Literature DB >> 24293170

Cryptococcal meningitis in Senegal: epidemiology, laboratory findings, therapeutic and outcome of cases diagnosed from 2004 to 2011.

Doudou Sow1, Roger Clément Tine, Khadime Sylla, Mansata Djiba, Cheikh Tidiane Ndour, Thérèse Dieng, Jean Louis Ndiaye, Babacar Faye, Daouda Ndiaye, Oumar Gaye, Yémou Dieng.   

Abstract

BACKGROUND: Cryptococcal meningitis is one of the most important opportunistic infection and a major contributor to early mortality. In sub-Saharan Africa, particularly in Senegal, prevalence of cryptococcal meningitis remains high. This study aimed to describe the epidemiology, laboratory profile, therapeutic and outcome of cases diagnosed in Dakar.
METHODS: We analyzed the cryptococcosis cases diagnosed at the department of parasitology-mycology in Fann Teaching Hospital in Dakar from 2004 to 2011. The diagnosis was confirmed by culture on Sabouraud's dextrose agar and/or by India ink preparation and/or by cryptococcal antigen detection. The diagnosis methods were assessed by using culture as reference.
RESULTS: A total of 106 cases of cryptococcal meningitis were diagnosed. The prevalence of cryptococcal meningitis was 7.8 %. The mean age of the patients was 40.17 ± 9.89 years. There were slightly more male (53.8 %) than female (46.2 %) patients; 89.6 % were found to be infected with HIV, and the median CD4+ count was 27/mm(3). Approximately 79.5 % of the patients had <100 CD4+ lymphocytes/mm(3). India ink staining presented sensitivity at 94.11 % and specificity at 100 %. Sensitivity and specificity of cryptococcal antigen detection in cerebrospinal fluid were, respectively, 96.96 and 15.78 %. The most frequently used antifungal drug was fluconazole (86.7 %), and the mortality rate was 62.2 % (66 deaths).
CONCLUSION: Early diagnosis is essential to control cryptococcosis, and countries should prioritize widespread and reliable access to rapid diagnostic cryptococcus antigen assays. But it is important to make available conventional methods (India ink and culture) in the maximum of laboratory in regional health facilities.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24293170     DOI: 10.1007/s11046-013-9710-8

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  26 in total

1.  Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients.

Authors:  J G Hakim; I T Gangaidzo; R S Heyderman; J Mielke; E Mushangi; A Taziwa; V J Robertson; P Musvaire; P R Mason
Journal:  AIDS       Date:  2000-07-07       Impact factor: 4.177

2.  [Epidemiological, clinical and prognostic aspects of cryptococcal meningitis in hospital area of Bamako, Mali].

Authors:  A A Oumar; S Dao; M Ba; B Poudiougou; A Diallo
Journal:  Rev Med Brux       Date:  2008 May-Jun

3.  [Neuromeningeal cryptococcosis and AIDS: an 11-case series from Libreville, Gabon].

Authors:  M Ondounda; D Mounguengui; Lawson J M Mandji; C Magne; Madjinou M I C Nziengui; U Kombila; J R Nzenze
Journal:  Med Trop (Mars)       Date:  2010-08

4.  Prevalence of cryptococcosis among HIV-infected patients in Yaounde, Cameroon.

Authors:  J P Dzoyem; F A Kechia; G P Ngaba; P K Lunga; P J Lohoue
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

5.  Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus.

Authors:  Elizabeth L Corbett; Gavin J Churchyard; Salome Charalambos; Badara Samb; Vicky Moloi; Tim C Clayton; Alison D Grant; Jill Murray; Richard J Hayes; Kevin M De Cock
Journal:  Clin Infect Dis       Date:  2002-04-05       Impact factor: 9.079

6.  Early mycological treatment failure in AIDS-associated cryptococcal meningitis.

Authors:  P A Robinson; M Bauer; M A Leal; S G Evans; P D Holtom; D A Diamond; J M Leedom; R A Larsen
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

7.  [Cryptococcal meningitis in HIV-infected patients at Bobo-Dioulasso hospital (Burkina Faso)].

Authors:  A Millogo; G A Ki-Zerbo; J B Andonaba; D Lankoandé; A Sawadogo; I Yaméogo; A B Sawadogo
Journal:  Bull Soc Pathol Exot       Date:  2004-05

Review 8.  Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.

Authors:  Benjamin J Park; Kathleen A Wannemuehler; Barbara J Marston; Nelesh Govender; Peter G Pappas; Tom M Chiller
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

9.  [Update on neuromeningeal cryptococcosis in Dakar].

Authors:  M Soumaré; M Seydi; C T Ndour; Y Dieng; A M Diouf; B M Diop
Journal:  Med Trop (Mars)       Date:  2005-11

10.  Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda.

Authors:  M Okongo; D Morgan; B Mayanja; A Ross; J Whitworth
Journal:  Int J Epidemiol       Date:  1998-08       Impact factor: 7.196

View more
  6 in total

1.  Comparison of different in vitro tests to detect Cryptococcus neoformans not susceptible to amphotericin B.

Authors:  Susana Córdoba; Walter Vivot; Wanda Szusz; Guillermina Isla; Graciela Davel
Journal:  Mycopathologia       Date:  2015-02-21       Impact factor: 2.574

2.  Usefulness of MALDI-TOF Mass Spectrometry for Routine Identification of Candida Species in a Resource-Poor Setting.

Authors:  Doudou Sow; Bécaye Fall; Magatte Ndiaye; Bissoume Sambe Ba; Khadime Sylla; Roger Tine; Aminata Collé Lô; Annie Abiola; Boubacar Wade; Thérèse Dieng; Yémou Dieng; Jean Louis Ndiaye; Christophe Hennequin; Oumar Gaye; Babacar Faye
Journal:  Mycopathologia       Date:  2015-05-28       Impact factor: 2.574

Review 3.  Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy.

Authors:  David Meya; Radha Rajasingham; Elizabeth Nalintya; Mark Tenforde; Joseph N Jarvis
Journal:  Curr Trop Med Rep       Date:  2015

4.  CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; G Silling; E Schalk; W Heinz; J Panse; O Penack; M Christopeit; D Buchheidt; U Meyding-Lamadé; S Hähnel; H H Wolf; M Ruhnke; S Schwartz; G Maschmeyer
Journal:  Ann Oncol       Date:  2016-04-06       Impact factor: 32.976

5.  MLST-Based Population Genetic Analysis in a Global Context Reveals Clonality amongst Cryptococcus neoformans var. grubii VNI Isolates from HIV Patients in Southeastern Brazil.

Authors:  Kennio Ferreira-Paim; Leonardo Andrade-Silva; Fernanda M Fonseca; Thatiana B Ferreira; Delio J Mora; Juliana Andrade-Silva; Aziza Khan; Aiken Dao; Eduardo C Reis; Margarete T G Almeida; Andre Maltos; Virmondes R Junior; Luciana Trilles; Volker Rickerts; Ariya Chindamporn; Jane E Sykes; Massimo Cogliati; Kirsten Nielsen; Teun Boekhout; Matthew Fisher; June Kwon-Chung; David M Engelthaler; Marcia Lazéra; Wieland Meyer; Mario L Silva-Vergara
Journal:  PLoS Negl Trop Dis       Date:  2017-01-18

6.  Increased mortality among HIV infected patients with cryptococcal antigenemia in Guinea-Bissau.

Authors:  Ditte Thomsen; Cecilie Juul Hviid; Bo Langhoff Hønge; Candida Medina; David Da Silva Té; Faustino Gomes Correira; Lars Østergaard; Christian Erikstrup; Christian Wejse; Alex Lund Laursen; Sanne Jespersen
Journal:  Pan Afr Med J       Date:  2018-01-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.